Surgical Design Studio Appoints Commercialisation CEO

Press Release
Source: Surgical Design Studio Limited.
On: 4:00pm Auckland, Wednesday 8 May 2019

Companies: Surgical Design Studio Limited.

Surgical Design Studio, a provider of innovative medical devices for gastrointestinal surgery, today announces the appointment of Garth Sutherland as Chief Executive Officer to lead the company in its commercialisation phase of development.

Garth Sutherland has 30 years’ experience in the technology sector, including 18 years in the medical devices industry. Previously Garth founded digital health company Adherium. During this time Garth completed five rounds of capital raising a total of more than $50 million, including listing the company on the ASX and subsequent institutional rounds. Garth led the establishment of Adherium’s AstraZeneca partnership, and built the team, technology, IP, and manufacturing partnerships. Garth has also worked internationally for a number of leading high technology companies including Microsoft, and has a M.Sc. Physics with 1st class honours.

Garth takes on the CEO role from co-founder, company Director, and surgeon Associate Professor Greg O’Grady, who moves to the position of Chief Scientific Officer. Garth said “I am very excited to join Greg and the other exceptional team members to bring the company’s award-winning products to market. The devices are so meaningful in improving health outcomes and quality of life for a range of patients, including those with colorectal cancer.”

Greg said “At Surgical Design Studio we are developing a suite of clinical products that are breakthrough solutions for patients undergoing surgical treatment for colorectal diseases, including colorectal cancer. I am enormously proud of the creativity and excellence being achieved by our engineering team at Surgical Design Studio, and am delighted to have Garth Sutherland joining us to bring these innovative products to market.”

Chairman Rob Davidson said, “We thank Greg sincerely for the key leadership role he has played in founding and growing SDS to be ready for commercialisation, and warmly welcome Garth to the team.”

About Surgical Design Studio

Surgical Design Studio (SDS) is a privately held medical devices developer based in Auckland, New Zealand, founded in 2017. SDS’s innovative technologies have been spun out from an international centre of research excellence at the Department of Surgery and Auckland Bioengineering Institute, the University of Auckland. The product pipeline SDS are developing has received numerous awards for design excellence and clinical impact. The mission of SDS is to bring transformative solutions to patients with colorectal cancer and other gastrointestinal diseases, to eliminate complications and improve quality of life.

Garth Sutherland, CEO
[email protected]